| Product Code: ETC6756118 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Veterinary Oncology Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Veterinary Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 China Veterinary Oncology Market - Industry Life Cycle |
3.4 China Veterinary Oncology Market - Porter's Five Forces |
3.5 China Veterinary Oncology Market Revenues & Volume Share, By Animal Type, 2021 & 2031F |
3.6 China Veterinary Oncology Market Revenues & Volume Share, By Theraphy, 2021 & 2031F |
3.7 China Veterinary Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
4 China Veterinary Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing pet ownership and humanization of pets in China |
4.2.2 Rising awareness about the availability of advanced veterinary oncology treatments |
4.2.3 Growth in disposable income leading to higher spending on pet healthcare |
4.3 Market Restraints |
4.3.1 Limited availability of specialized veterinary oncology services in certain regions of China |
4.3.2 High cost associated with advanced veterinary oncology treatments |
4.3.3 Lack of insurance coverage for veterinary oncology care in China |
5 China Veterinary Oncology Market Trends |
6 China Veterinary Oncology Market, By Types |
6.1 China Veterinary Oncology Market, By Animal Type |
6.1.1 Overview and Analysis |
6.1.2 China Veterinary Oncology Market Revenues & Volume, By Animal Type, 2021- 2031F |
6.1.3 China Veterinary Oncology Market Revenues & Volume, By Canine, 2021- 2031F |
6.1.4 China Veterinary Oncology Market Revenues & Volume, By Feline, 2021- 2031F |
6.1.5 China Veterinary Oncology Market Revenues & Volume, By Equine, 2021- 2031F |
6.2 China Veterinary Oncology Market, By Theraphy |
6.2.1 Overview and Analysis |
6.2.2 China Veterinary Oncology Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 China Veterinary Oncology Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.4 China Veterinary Oncology Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.2.5 China Veterinary Oncology Market Revenues & Volume, By Other Therapies, 2021- 2031F |
6.2.6 China Veterinary Oncology Market Revenues & Volume, By Radiotherapy, 2021- 2031F |
6.3 China Veterinary Oncology Market, By Cancer Type |
6.3.1 Overview and Analysis |
6.3.2 China Veterinary Oncology Market Revenues & Volume, By Skin Cancers, 2021- 2031F |
6.3.3 China Veterinary Oncology Market Revenues & Volume, By Lymphomas, 2021- 2031F |
6.3.4 China Veterinary Oncology Market Revenues & Volume, By Sarcomas, 2021- 2031F |
6.3.5 China Veterinary Oncology Market Revenues & Volume, By Others, 2021- 2031F |
7 China Veterinary Oncology Market Import-Export Trade Statistics |
7.1 China Veterinary Oncology Market Export to Major Countries |
7.2 China Veterinary Oncology Market Imports from Major Countries |
8 China Veterinary Oncology Market Key Performance Indicators |
8.1 Number of veterinary oncology clinics and hospitals in China |
8.2 Adoption rate of new veterinary oncology treatments and technologies |
8.3 Number of veterinary oncology specialists in China |
8.4 Research and development investment in veterinary oncology treatments |
8.5 Patient outcomes and survival rates for veterinary oncology cases |
9 China Veterinary Oncology Market - Opportunity Assessment |
9.1 China Veterinary Oncology Market Opportunity Assessment, By Animal Type, 2021 & 2031F |
9.2 China Veterinary Oncology Market Opportunity Assessment, By Theraphy, 2021 & 2031F |
9.3 China Veterinary Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
10 China Veterinary Oncology Market - Competitive Landscape |
10.1 China Veterinary Oncology Market Revenue Share, By Companies, 2024 |
10.2 China Veterinary Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here